Latest Breaking News On - Rhonna shatz - Page 1 : comparemela.com
UC Health one of three sites in Ohio to provide new Alzheimerâs treatment Share Updated: 11:22 AM EDT Jun 9, 2021 WLWT Digital Staff Share Updated: 11:22 AM EDT Jun 9, 2021
Hide Transcript
Show Transcript REPORTER: SOME ARE CALLING THIS AIG B SPTE FORRDWA IT DOES COME WITH CONTROVERSY. A CONTROVERSIAL ALZHEIMER S TREAENTTM FROM CAMBRIDGE BASED BIOGEN GETTING THE FDA STAMP OF APPROVAL. IT S THE FIRST DRUG OF ITS KIN BACKED BY THE FDA TO TREAT THE ACTUAL UNDERLYING DISEASE, AND NOT JUST SYTO.MP IT S A VERY IMPORTANT FIRST STEP IN THE TREATMENT OF ZHEIALMER S DEASEIS THE TATREMENT HAD NOT BEEN SWNHO TO HELP. THEY SAW GOOD RESULT FOR PEOPLE IN THE EARLY STAGES. THIS IS FOR PEOPLE WHO HAVE ATWH WE CALL MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER S DISEASE OR VERY MILD DISEASE. REPORTER: BIOGEN CEO SAYS THIS HISTORIC MOMENTHE T CULMINATION OF GROUNDBREINAK RESEARCH. MEDICINE WILL TRANSFORM THE TREATMENT OF PEOPLE LIVING WITH ALZHEI
University-of-cincinnati
Ohio
United-states
Cambridge
Cambridgeshire
United-kingdom
Bob-heimann
Rhonna-shatz
Aducanumab-uc-health
Us-food-drug-administration-on
Uc-memory-disorders-center
Uc-health
vimarsana © 2020. All Rights Reserved.